OVERVIEW

Venous Thromboembolism - Risk Assessment is organized by AcademicCME and will be held from Aug 07, 2024 - Aug 06, 2025.

Start Date: Aug 7, 2024
End Date: Aug 6, 2025

Description:
This installment in our joint-accredited educational series on the management of venous thromboembolism addresses risk assessment and the overlapping risk factors and prevalence considerations for VTE. Thrombosis researcher, Charles Pollack, MD, works through the complex data on individual and additive risk concerns and how those contribute to there now being an overall prevalence of 1 in 12 adults globally experiencing at least one VTE event during their lifetime.

Learning Objectives:

  • Review strategies for prevention, risk assessment, and incidence in the management of patients with VTE
Credits

Accreditation:
AcademicCME designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM.

AcademicCME designates this enduring material for a maximum of 0.75 CNE Contact Hours.

AcademicCME designates this continuing education activity for 0.75 CPE Contact Hours (0.075 CEUs) of continuing pharmacy education credit (UAN # JA4008190-0000-24-002-H01-P.)

  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 CPE
  • 0.75 CNE
  • TARGET AUDIENCE

    PhysicianCardiologistsHealthcare ProfessionalsFamily MedicineInternistHematologistHealthcare ProvidersPrimary Care PhysiciansPulmonologistsAllied Health Professionals

    SPECIALITIES

    HaematologyPulmonologyCardiology

    RELATED ONLINE COURSES

    Webcast

    Emergency Medicine
    More actions
    US$200

    Webcast

    Pediatrics
    28 AMA PRA Category 1 Credits™
    More actions
    US$910